| International Drug Names|
UK: POM (Prescription only)
In general: ℞ (Prescription only)
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).
Allergy to sulfonylureas or sulfonamides
Diabetes mellitus type 1
Patients that underwent removal of the pancreas
Severe liver disease accompanying with liver insufficiency
Several conditions (e.g., infectious diseases or major surgical intervention), when insulin administration is required
Pregnancy or breastfeeding
Gliquidone is fully metabolized by the liver. Its metabolites are excreted virtually completely with bile (even with long-term administration), thus allowing the use of medication in diabetic patients suffering from kidney disease and diabetic nephropathy.